Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class ITerminatedFeb 1, 2023Advil (ibuprofen) TabletsLabeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled backGlaxosmithkline Consumer Healthcare Holdings DBA Haleon · D-0181-2023Class ITerminatedFeb 1, 2023EpinephrineDiscoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective productSpectrum Laboratory Products, Inc. · D-0180-2023Class ITerminatedFeb 1, 2023EpinephrineDiscoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective productSpectrum Laboratory Products, Inc. · D-0179-2023Class IITerminatedFeb 1, 2023Sterile Water for InjectionCGMP Deviations: potential for trace amounts of product carryover.Nephron Sc Inc · D-0178-2023Class IITerminatedFeb 1, 20230.9% Sodium Chloride InjectionCGMP Deviations: potential for trace amounts of product carryover.Nephron Sc Inc · D-0177-2023Class IITerminatedFeb 1, 2023S2 Racepinephrine Inhalation SolutionShort FillNephron Sc Inc · D-0176-2023Class IITerminatedFeb 1, 2023Asthmanefrin Racepinephrine Inhalation Solution BronchodilatorShort FillNephron Sc Inc · D-0175-2023Class IIITerminatedFeb 1, 2023Clobetasol propionate Cream USPSubpotent Drug: Low assay result observed during long-term stability testing.Lupin Pharmaceuticals Inc. · D-0174-2023Class IITerminatedFeb 1, 2023Allopurinol Tablets 100mgPresence of Foreign Substance: manufacturer recalled this re-packaged product due to reports of a small piece of green plastic embedded in the crack towards the edge of...Preferred Pharmaceuticals, Inc. · D-0173-2023Class IIITerminatedFeb 1, 2023FentaNYL Citrate 2.5mg/50mLShort Fill: Underfilled units.OurPharma LLC · D-0172-2023Class IITerminatedFeb 1, 2023Metoprolol Succinate Extended-Release TabletsFailed Dissolution SpecificationAscend Laboratories, LLC · D-0171-2023Class IITerminatedFeb 1, 2023Metoprolol Succinate Extended-Release TabletsFailed Dissolution SpecificationAscend Laboratories, LLC · D-0170-2023Class IITerminatedFeb 1, 2023Metoprolol Succinate Extended-Release TabletsFailed Dissolution SpecificationAscend Laboratories, LLC · D-0169-2023Class IITerminatedFeb 1, 2023Allopurinol Tablets USPPresence of Foreign Substance: Presence of a small piece of green plastic embedded in the crack towards the edge of the tablet.Accord Healthcare, Inc. · D-0168-2023Class IIITerminatedJan 25, 2023SINUVA (mometasone furoate) sinus implantFailed Dissolution Specification; product did not meet the average 24-hour drug release rate (dissolution) specification stability time point at 9 months.Intersect ENT, Inc. · D-0167-2023Class IIOngoingJan 25, 2023SIREtizer Hand SanitizerCGMP Deviations and Superpotent Drug: Levels of acetal and acetaldehyde above allowable limits. Additionally, lot 001 was superpotent.Southwest Iowa Renewable Energy LLC · D-0166-2023Class IITerminatedJan 25, 2023Rifampin Capsules USPFailed Impurities/Degradations SpecificationsAmerisource Health Services LLC · D-0165-2023Class IIOngoingJan 25, 2023Hand SanitizerCGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced...Fisher Scientific Co., LLC · D-0164-2023Class IIOngoingJan 25, 2023Hand SanitizerCGMP Deviations: Voluntary recall of all hand sanitizer distributed after March 31, 2022, due to FDA issued guidance to cease placing hand sanitizer product, produced...Fisher Scientific Co., LLC · D-0163-2023Class IIITerminatedJan 25, 2023Levofloxacin TabletsMismatching of the embossing on the tablets (T7) with the embossing mentioned in the package insert (ML63) in the distributed bottles.Macleods Pharma USA, Inc · D-0162-2023Class IIITerminatedJan 25, 2023Triamterene and Hydrochlorothiazide CapsulesFailed Impurity/Degradation SpecificationsLannett Company Inc. · D-0161-2023Class IIITerminatedJan 25, 2023Triamterene and Hydrochlorothiazide CapsulesFailed Impurity/Degradation SpecificationsLannett Company Inc. · D-0160-2023Class IITerminatedJan 25, 2023Rasagiline Mesylate Tablets 1 mgPresence of Foreign Substance- A complaint was received of black spots/shiny metallic speck on the tablets.Ascend Laboratories, LLC · D-0159-2023Class IIOngoingJan 25, 2023Tobramycin Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0158-2023Class IIOngoingJan 25, 2023Tobramycin Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0157-2023Class IIOngoingJan 25, 2023Timolol Maleate Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0156-2023Class IIOngoingJan 25, 2023Sodium Chloride Ophthalmic OintmentCGMP Deviations:Akorn, Inc. · D-0155-2023Class IIOngoingJan 25, 2023Proparacaine Hydrochloride Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0154-2023Class IIOngoingJan 25, 2023Proparacaine Hydrochloride Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0153-2023Class IIOngoingJan 25, 2023PAREMYDCGMP Deviations:Akorn, Inc. · D-0152-2023Class IIOngoingJan 25, 2023Olopatadine HCl Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0151-2023Class IIOngoingJan 25, 2023Olopatadine HCl Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0150-2023Class IIOngoingJan 25, 2023Olopatadine HCl Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0149-2023Class IIOngoingJan 25, 2023Olopatadine HCL Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0148-2023Class IIOngoingJan 25, 2023Olopatadine HCl Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0147-2023Class IIOngoingJan 25, 2023Ofloxacin Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0146-2023Class IIOngoingJan 25, 2023Neomycin and Polymyxin B SulfatesCGMP Deviations:Akorn, Inc. · D-0145-2023Class IIOngoingJan 25, 2023Moxifloxacin Ophthalmic SolutionCGMP Deviations:Akorn, Inc. · D-0144-2023Class IIOngoingJan 25, 2023Lidocaine Hydrochloride Jelly USPCGMP Deviations:Akorn, Inc. · D-0143-2023Class IIOngoingJan 25, 2023Levofloxacin Ophthalmic Solution 0.5%CGMP Deviations:Akorn, Inc. · D-0142-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.